-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeUSDISIN US7170811035-
PfizerBörse NYSE New York Stock ExchangeISIN US7170811035 WKN: 852009USDSymbol PFE
-
PfizerBörse Börse StuttgartISIN US717081DK61EURSymbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081ER06EURSymbol PFE
-
PFIZER INCBörse Börse HamburgISIN US717081ED10EURSymbol PFE
-
PFIZER INCBörse Börse DüsseldorfISIN XS1574158082EURSymbol PFE
-
PFIZER INCBörse Börse MünchenISIN US717081DZ31EURSymbol PFE
-
PFIZER INCBörse Gettex System der Börse MünchenISIN US717081ES88EURSymbol PFE
-
PFIZER INCBörse Tradegate System der Deutsche Börse AG (60%)ISIN US717081EQ23EURSymbol PFE
-
PFIZER INCBörse Quotrix System der Börse DüsseldorfISIN US717081DE02EURSymbol PFE
-
PFIZER INCBörse Börse FrankfurtISIN XS1574157357EURSymbol PFE
-
PfizerBörse Xetra FrankfurtEURISIN US717081EY56
-
PfizerBörse Börse MünchenEURISIN US717081FA61
-
PfizerBörse SSE Stockholm Stock ExchangeISIN US717081EZ22SEKSymbol PFE
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081EK52MXNSymbol PFE
-
PfizerBörse Bolsa de Comercio de Buenos AiresUSDISIN US717081DV27
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US717081DH33
-
PfizerBörse BUEUSDISIN US717081EV18
-
ISIN US717081EX73EURSymbol PFE
-
PfizerBörse OMXSSEKISIN US7170811035
-
EURISIN US717081EJ89
-
PFIZER INCBörse SSEISIN US717081EP40
-
ISIN US7170811035
WKN 852009
Symbol PFE
Währung
USD
Börse
NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname
Pfizer Inc
Marktkapitalisierung
197.500.079.920 (+- 10%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
204.882.624.512 oder 216.419.000.000 oder 171.198.615.249
Mitarbeiter
83.400 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
88.300 oder 78.500 Mitarbeiter
Anzahl Aktien
5.558.396.599
KGV
18.68 (+- 28%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
23.97 oder 13.4
EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744
Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 4,02 % p. a.
beim aktuellen Kurs von 36,59 USD -0,04%
Pfizer underperformed den DAX um -13 % (+31 % Dividenden) vom 27.11.2013 bis 14.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 36,59 USD -0,04%
Letzte Communitymeinungen
- 2 User waren zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
casixxx
-
Harry386
Ein User hat Pfizer abonniert.
Aktionärsstruktur der Pfizer Inc
Portrait der Pfizer Aktie
Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.
Die Pfizer Aktie hat inklusive der Dividendenausschüttungen seit dem 27.11.2013 eine Gesamtrendite von 85% erwirtschaftet
Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
1.033 News & Informationen zur Pfizer Aktie
Moderna COVID-19 vaccine gets EU regulator endorsement for teens By Reuters
Moderna COVID-19 vaccine gets EU regulator endorsement for teens
Arvinas (ARVN), Pfizer Team up for Breast Cancer Therapy
Arvinas (ARVN) collaborates with Pfizer for its investigational breast cancer candidate, ARV-471. Pfizer is also set to acquire an equity stake in Arvinas. The stock rises 9% post the announcement.
Will Pfizer (PFE) Beat Expectations This Earnings Season?
Higher sales of Pfizer's (PFE) key brands, Eliquis, Xeljanz, and Inlyta, and revenues from COVID-19 vaccine are likely to have driven sales in the second quarter.
Pfizer shot halts severe illness, allows infection in Israel
The vaccine, developed with BioNTech SE, provided 88% protection against hospitalization and 91% against severe illness for an unspecified number of people studied between June 20 and July 17, according to a report Thursday from the health ministry
BioNTech : Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S (Form 6-K)
Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
… | July 23, 2021
Pfizer says US govt buying 200 million more doses of COVID-19 vaccine
The government has an option to buy an updated version of the vaccine to address potential variants as well as new formulations of the vaccine, if available and authorized, the companies said
Pfizer, BioNTech to Sell Further 200 Million Covid-19 Vaccine Doses to U.S. Government
By Robb M. Stewart
Pfizer Inc. and BioNTech SE have agreed to supply an additional 200 million doses of their Covid-19 vaccine to the U.S. government, bringing the total under their existing… | July 23, 2021
Pfizer, BioNTech Say U.S. Government To Buy Addl 200 Mln Doses Of COVID-19 Vaccine – Quick Facts
(RTTNews) – Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday that the U.S. government has purchased an additional 200 million doses of th…
Why BioNTech, Moderna, and Novavax Stocks Soared This Week
Concerns about the delta variant are rising.
Earnings scheduled for the week of 7/26/2021
Major companies tentatively scheduled to post quarterly earnings next week
Can Today's Vaccines Beat the Delta Variant?
Moderna, Pfizer, and Johnson & Johnson are optimistic.
Is the Next Covid Game Changer a Pill?
(Bloomberg Opinion) — Vaccines have been game changers in the fight against Covid-19, offering effective protection against even highly contagious and pathogenic strains such as the delta variant.
Longer gap between Pfizer doses boosts antibodies, study finds
An interval of eight to 10 weeks between doses of the Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE boosts the effectiveness of the two-shot regimen compared with a shorter interval, a U.K. study found.
Australian officials tighten Sydney lockdown as COVID-19 cases rise By Reuters
Australian officials tighten Sydney lockdown as COVID-19 cases rise
TGA approves Pfizer vaccine for kids aged 12-15 years old
The Pfizer Inc (NYSE: PFE) COVID-19 vaccine has been approved for use in children aged 12-15 years in Australia.
U.S. Vaccine Panel Signals Preliminary Support for Covid-19 Booster Shots
A U.S. advisory panel on vaccines expressed preliminary support for giving Covid-19 boosters to the immunocompromised, and endorsed continued use of the Johnson & Johnson vaccine despite a recent health-risk warning.
U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports By Reuters
U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports
U.S. CDC advisers mull COVID-19 boosters for immune-compromised people
CHICAGO — Advisers to the U.S. Centers for Disease Control and Prevention on Thursday will consider evidence suggesting that a booster dose of COVID-19…
Why Arvinas Jumped 10% Today
The smaller biopharma outfit just inked an encouraging deal with an industry powerhouse.
Moderna : U.S. CDC advisers back J&J COVID-19 vaccine benefits amid neurological illness reports
Despite reports of a rare neurological
disorder appearing in some people who have received Johnson &
Johnson's COVID-19 vaccine, the benefits of its use
outweigh the risks, a U.S. Centers for… | July 22, 2021
CDC guidance on masking unchanged as Delta variant sweeps U.S.
CDC guidance on masking unchanged as Delta variant sweeps U.S. – Walenksy
Arvinas Shares Rise 10% After Collaboration Deal With Pfizer
By Chris Wack
Arvinas Inc. shares were up 10% to $85.17 Thursday after the company said it and Pfizer Inc. entered into a global collaboration to develop and commercialize ARV-471, an… | July 22, 2021
CDC advisers consider boosters for immune-compromised Americans By Reuters
CDC advisers consider boosters for immune-compromised Americans
Moderna : CDC advisers consider boosters for immune-compromised Americans
Advisers to the U.S. Centers
for Disease Control and Prevention on Thursday will consider
evidence suggesting that a booster dose of COVID-19 vaccines
could increase protection among people with… | July 22, 2021
GSK appoints consumer head as CEO of new spin-off
British drugmaker GSK said on Thursday its consumer healthcare head, Brian McNamara, will take over as the chief executive officer of the unit once it is spun…
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Global Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period – by PMI
Covina, CA, July 22, 2021 (GLOBE NEWSWIRE) — The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$…
Pfizer (PFE) Inks Vaccine Deal, Faces FDA Delay on JAK Drugs
Pfizer (PFE) partners with Biovac for manufacturing and distributing its COVID-19 vaccine in African Union. The FDA delays decision on Pfizer's regulatory filings for JAK inhibitors.
Is the next Covid-19 game changer a pill?
With many in the world still unvaccinated and cases on the rise, we’ll need more than shots to keep the virus at bay. Antiviral pills may fill the gap
Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases
/PRNewswire/ — According to WebMD, this week the nation's top health officials said Tuesday that the Delta variant of the coronavirus is racing through North…
Outlook On The Nutritional Supplements Global Market To 2027 – Trend Forecasts And Growth Opportunities
DUBLIN, July 22, 2021 /PRNewswire/ — The “Global Nutritional Supplements Market 2020-2027 by Ingredient, Product Form, Category, Application, End User,
Pfizer, Arvinas Ink Deal To Develop And Commercialize PROTAC Protein Degrader ARV-471 – Quick Facts
(RTTNews) – Pfizer Inc. (PFE) and Arvinas, Inc. (ARVN) announced Thursday a global collaboration to develop and commercialize ARV-471, an investig…
Antares Pharma Announces FDA Acceptance Of IND Application For ATRS-1902 For Adrenal Crisis Rescue
EWING, N.J., July 22, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. ATRS (“the Company”), a specialty pharmaceutical company, today announced that the U.S. Food
Why Covid-19 Vaccines Work Well Against Delta Variant
The design of the shots helps them guard against the contagious new strain, though people will probably need two doses to get full protection.
2 Dirt Cheap Dividend Stocks You Can Buy Right Now
They may not remain cheap for much longer.
How Big of an Impact Will COVID-19 Have on the Stock Market Going Forward?
Coronavirus variants will be the key variable.